Top Markets
#1 DogBull DogBull +54.65%
#2 Siren Siren +31.05%
#3 OriginTrail OriginTrail +17.89%
#4 Purr Purr +12.64%
#5 Yield Basis Yield Basis +11.36%
#6 龙虾 (Lobster) 龙虾 (Lobster) +10.15%
#7 Stargate Finance Stargate Finance +8.65%
#8 Cysic Cysic +8.61%
#9 COTI COTI +7.71%
#10 MetYa MetYa +7.40%
Coin of the day
DogBull DogBull
Innstillinger
Språk
NORSK
Valuta
USD
Tema
ABIONYX Pharma S.A. ABIONYX Pharma S.A.

ABIONYX Pharma S.A.

ABNX
Rangering i aksjer #21916
ABIONYX Pharma SA is a biotechnology company dedicated to the identification... ABIONYX Pharma SA is a biotechnology company dedicated to the identification and advancement of therapies for conditions affecting the kidneys and eyes. The firm's pipeline includes CER-001, an innovative negatively-charged lipoprotein particle. This compound is designed to mimic the structural and functional attributes of pre-beta HDL, utilizing human recombinant apoA-I (a natural high-density lipoprotein protein) along with natural phospholipids like sphingomyelin and dipalmitoylphosphatidylglycerol. CER-001 is currently under development for patients recovering from acute coronary syndrome and those with familial primary hypoalphalipoproteinemia. Another key candidate, CER-002, is a specific agonist for peroxisome proliferator-activated receptor delta, targeting cardiovascular and metabolic diseases. Additionally, CER-209 is being developed as a potential treatment for metabolic liver diseases, atherosclerosis, and non-alcoholic steatohepatitis (NASH). ABIONYX maintains strategic partnerships with GTP Biologics and VBI Therapeutics Group for the bioproduction of its bio-HDL in France. Established in 2005, the company operated as Cerenis Therapeutics Holding SA before its rebranding to ABIONYX Pharma SA in August 2019. Its operations are headquartered in Balma, France.
Aksjekurs
$2.32
Sist synkronisert: 2026-08-21
Markedsverdi
$98.03M
Endring (1 dag)
-1.91%
Endring (1 år)
-5.84%
Land
FR
Handel ABIONYX Pharma S.A. (ABNX)

Kategori

Healthcare
Aksjeprishistorikk for ABIONYX Pharma S.A. (ABNX)
Høyeste sluttskurs: $2.33 den 2026-08-01

Laveste sluttskurs: $13.49 den 2015-03-01
Aksjeprishistorikk for ABIONYX Pharma S.A. fra 2015 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -8.81%
2025 224.23%
2024 -8.82%
2023 -24.48%
2022 -34.42%
2021 158.51%
2020 191.80%
2019 -43.09%
2018 -69.75%
2017 -74.56%
2016 -34.40%
2015 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $547.71 38.62%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 58.06%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $145.75 437.43%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $118.70 -15.60%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $770.19 8.98%
CH